Fundraising Fox

Chiasma

Newton Centre, US · Delaware corporation · 3 known investors

Biotech

Founders & leadership

CO
Chaime OrlevExecutive
RM
Roni MamlukExecutive

Board

SM
Scott MinickinMember Board of Directors2007–2019Managing Director at ARCH Venture Partners
TTTodd T. Foley
Todd T. FoleyinBoard directorManaging Director at MPM BioImpact
VM
Vincent MilesBoard director
AKAnsbert K. Gadicke
Ansbert K. GadickeinBoard directorChairman at MPM BioImpact
DB
Dror BrandweinBoard director
BJ
Bard J. GeesamaninBoard directorManaging Partner at MPM Capital
DM
David M. StackinBoard directorManaging Partner at MPM Capital
JA
John A. ScarlettBoard director

Investors · 3

HEALTHCARE ROYALTY PARTNERSNew York
Sofinnova VenturesMenlo Park · $100K – $15M
MPM BioImpactreportedBoston · $1M – $15Mvia Ansbert K. Gadicke · board

Reported raises · per SEC filings

Form D private placements

$69.7M disclosed across 1 round · 2014

▶$69.7MraisedMar 2015 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott MinickDirector
  • John A. ScarlettDirector
  • Chaime OrlevExecutive Officer
  • Todd T. FoleyDirector
  • Vincent MilesDirector
  • Ansbert K. GadickeDirector
  • Roni MamlukExecutive Officer, Director
  • Dror BrandweinDirector
  • Bard J. GeesamanDirector
  • David M. StackDirector
Offering amount
$87.2M
Amount sold
$69.7M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Chiasma went on to found or lead other companies.

Todd FoleyDirectorFounded Aktis OncologyAnsbert Gadicke, M.D.DirectorFounded MpmcapitalJessica TulpEvents SupportFounded Rocket Lab

In the news

Nasdaq-Listed Biopharma Company Chiasma Raises $34.5 Million in Public Offering - CTechcalcalistech.com · Apr 2019Chiasma Pharma Raises $70M In Series E Fundingnocamels.com · Mar 2015Chiasma Announces Completion of $70 Million Series E Financing | Fierce Biotechfiercebiotech.com · Feb 2015Chiasma closes multimillion-dollar funding to support oral acromegaly trial | Fierce Pharmafiercepharma.com · Jul 2012Chiasma Raises $44 Million Series C To Fund Clinical Testing, Advance Technology - BioSpacebiospace.com · Nov 2006Chiasma Scores Huge $44 Million Funding - Businesshaaretz.com · Nov 2006

Frequently asked questions

Who are Chiasma's investors?
Chiasma's investors include HEALTHCARE ROYALTY PARTNERS, Sofinnova Ventures, MPM BioImpact.
How much funding has Chiasma raised?
Chiasma has disclosed $69.7M raised across 1 round.
Where is Chiasma headquartered?
Chiasma is headquartered in Newton Centre, US.